MESA LABORATORIES INC /CO/
Financial highlights
| Metric | FY March 31, 2025 | FY March 31, 2024 | FY March 31, 2023 | FY March 31, 2022 | FY March 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $241.0M | $216.2M | $219.1M | $184.3M | $133.9M |
| Gross profit | $150.9M | $133.2M | $133.7M | $109.1M | $87.0M |
| Operating income | $16.3M | -$272.1M | $3.3M | $4.7M | $12.4M |
| Operating expenses | $134.5M | $405.3M | $130.4M | $104.4M | $74.7M |
| Cost of revenue | $90.1M | $82.9M | $85.4M | $75.2M | $46.9M |
| Cash from operations | $46.8M | $44.1M | $28.0M | $39.2M | $37.1M |
| Capital expenditure | $4.2M | $2.6M | $4.5M | $4.4M | $2.0M |
| Free cash flow | $42.6M | $41.6M | $23.4M | $34.8M | $35.1M |
| Share repurchases | — | $0 | $0 | $0 | $0 |
| Impairments | $0 | $156.9M | $0 | $0 | $0 |
| Total assets | $433.3M | $446.8M | $661.8M | $707.4M | $601.5M |
| Total liabilities | $273.5M | $301.4M | $268.4M | $313.6M | $195.2M |
Shares outstanding 5.5M · Free float 93.8%
Annual filing data through FY ended March 31, 2025; float as of July 8, 2026.